HistologiX and Antibody Analytics partnerhsip blog hero final.png
Back to news
Strategic Partnership Announcement: Antibody Analytics and HistologiX

Antibody Analytics is excited to announce a strategic partnership with HistologiX, a company specialising in cellular and digital pathology services. As precision medicine is embraced and the number of targeted therapeutics continue to grow, this partnership provides our customers with access to our complementary capabilities, essential to accelerate the development of innovative therapeutic strategies.

Both companies can now provide access to a comprehensive range of services. For Antibody Analytics, our biomarker, immunopharmacology and immunotoxicology capabilities are extended with the ability to offer histology and digital pathology analysis of both animal and clinical samples. While HistologiX’ customers will benefit from access to our extensive platform of in vitro cell-based functional characterisation and immunology research services.

Dr. Agapitos Patakas, Antibody Analytics’ Chief Scientific Officer said, “HistologiX is one of the leaders in histology, image analysis and digital pathology and through this collaboration, Antibody Analytics is now able to provide more comprehensive support to our customers with target discovery, pre-clinical and clinical histology analysis needs.” 

“Antibody Analytics offers comprehensive in vitro immunopharmacology and immunotoxicology services from the very earliest stages of the drug discovery process, starting from target discovery, through lead identification and selection to product characterisation. Our partnership with HistologiX will expand this to immunohistochemical efficacy & toxicity biomarker assays (pre-clinical and clinical) and tissue cross reactivity (TCR) assessments. This is an exciting opportunity for both companies and allows expansion of our capabilities from early discovery to clinical testing for targeted biologics.” 

"We are delighted to be partnering with Antibody Analytics" said Barbara McManus Managing Director of HistologiX. "Their commitment to providing high-quality research services aligns perfectly with our own values, and we are excited to work together to offer even more advanced solutions to our customers and strengthen our offerings." 

We at Antibody Analytics place high value on collaboration and are delighted to partner with HistologiX, a company that helps scientists overcome obstacles from discovery to clinical with bespoke cellular and digital pathology services. 

Dr. Adele Hannigan
Director of Strategy
Published: 2022-12-14